Recent Updates
Recently added Catalysts
EHC Positive Sentiment Score: 65/100

Encompass Health announces private offering of senior notes

Key Takeaway: Encompass Health Corp. has announced a private offering of $500 million in senior notes maturing in 2034. The proceeds will be used to redeem $400 million of existing senior notes due 2028 and repay $100 million of its revolving credit facility. The offering is targeted at qualified institutional buyers and is subject to market conditions.
Price reaction · baseline $107.49 (2026-05-13 close) · hit after-hours · clean, no other EHC news in the window
day 0 close
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Encompass Health is raising $500 million through senior notes.
  • The funds will be used to redeem existing debt and strengthen financial position.
  • The company is recognized as a leader in inpatient rehabilitation.

CONCERNS & RISKS

  • The offering is subject to market conditions, which may affect completion.
  • Forward-looking statements indicate uncertainty regarding future events.

Full Press Release Details

BIRMINGHAM, Ala.,May 14, 2026/PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it has commenced a private offering of $500 million in aggregate principal amount of senior notes maturing in 2034 (the "Notes"), subject to market and other conditions. The Notes will be jointly and severally guaranteed on a senior unsecured basis by all of the Company's existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt.
The Company intends to use the net proceeds from the offering of the Notes, together with available cash on hand, to redeem at par $400 million in aggregate principal amount of its outstanding 4.500% Senior Notes due 2028, to repay $100 million of the outstanding amounts under the Company's senior secured revolving credit facility and to pay certain related fees and expenses in connection with the foregoing.
The Notes will be offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The offer and any sale of the Notes and the related guarantees have not been and will not be registered under the Securities Act or any state securities laws, and the Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.
This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release shall not constitute a notice of redemption with respect to the notes to be redeemed.
About Encompass HealthEncompass Health (NYSE:EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visitencompasshealth.com, or follow us on ournewsroom,X,InstagramandFacebook.
From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.
Forward-looking statementsStatements contained in this press release which are not historical facts, such as the likelihood, timing and effects of the completion of the private offering of the Notes, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health's ability to complete the offering of the Notes on the terms described or at all; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant disruption in the capital markets or economy; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Form 10-Q for the quarter ended March 31, 2026.

Media contact:Polly Manuel | 205-970-5912[email protected]

Investor relations contact:Mark Miller | 205-970-5860[email protected]

Frequently Asked Questions

What is the amount of the senior notes offering?

Encompass Health is offering $500 million in senior notes.

What will the proceeds from the notes be used for?

The proceeds will redeem $400 million of existing senior notes and repay $100 million of credit facility debt.

Who can purchase the senior notes?

The notes are offered to qualified institutional buyers and certain non-U.S. persons.

What are the maturity details of the senior notes?

The senior notes will mature in 2034.

Is the offering registered under the Securities Act?

No, the offering has not been registered under the Securities Act.

Last updated: May 14, 2026